Active Pharmacovigilance Study of the Medicine Rinvoq™ (Upadacitinib)

NCT06498167 · clinicaltrials.gov ↗

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Inflammatory Disease
Drug Side Effect
Drug Use
Adverse Drug Event
Adverse Drug Reaction
Safety Issues

Interventions

DRUG: Upadacitinib

Sponsor

Universidade do Porto

Collaborators

[object Object]
[object Object]
[object Object]
[object Object]
[object Object]
[object Object]